Related Experiment Video
Updated: Jul 18, 2026
07:33
A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
Published on: May 21, 2010
[Non-progressive congenital ataxias].
J Eirís-Puñal1, C Gómez-Lado, M Castro-Gago
1Servicio de Neuropediatría, Departamento de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain. eirisjm@wanadoo.es
Revista De Neurologia
|November 14, 2006
Summary
Non-progressive congenital ataxias (NPCA) are diverse neurological disorders with varied causes. Diagnosing NPCA is challenging, often requiring extensive testing, as genetic factors remain unknown in half of all cases.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Context:
- Non-progressive congenital ataxias (NPCA) represent a complex group of neurological disorders.
- Etiologies are diverse, encompassing environmental and genetic factors.
- Clinical presentation varies, with cerebellar signs appearing later or being absent in severe cases.
Purpose:
- To review the classification and diagnostic challenges of NPCA.
- To highlight the role of neuroimaging and complementary examinations.
- To discuss the current understanding of NPCA etiology and inheritance patterns.
Summary:
- NPCA diagnosis is complicated by heterogeneous presentations and potential extra-cerebellar involvement.
- Neuroimaging often shows cerebellar hypoplasia, though it can be normal.
- Extensive investigations, including metabolic and genetic tests, are crucial, yet causation remains unknown in approximately 50% of cases.
Impact:
- Improved understanding of NPCA heterogeneity and diagnostic pathways.
- Highlights the need for advanced diagnostic tools, including molecular genetics.
- Underscores the significant proportion of undiagnosed NPCA cases, driving future research.
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:25Secondary Spinal Cord Injury llI: Pathophysiology
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...